Total Iron-Binding Capacity (TIBC)
TIBC measures the maximum amount of ferric iron that can be bound by circulating plasma transferrin, serving as an indirect assay for transferrin protein concentration.
Standard vs. Optimal Reference Rangesμg/dL
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
250 - 450 μg/dL
General reference distribution across unselected commercial populations.
275 - 375 μg/dL
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Hepatocytes synthesize transferrin in inverse proportion to intracellular iron stores. In iron deficiency, hepatic transferrin gene expression increases to maximize iron capture.
Differential Diagnosis
Elevated Levels (TIBC High)
- •Iron deficiency anemia (compensatory hepatic synthesis)
- •Oral contraceptive use / Pregnancy (estrogen effect)
Low Levels (TIBC Low)
- •Anemia of chronic disease / Inflammation (transferrin is a negative acute-phase reactant)
- •Hemochromatosis / Iron overload
- •Cirrhosis / Protein malnutrition
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Venipuncture must be performed in the morning (between 7:00 AM and 10:00 AM) due to pronounced diurnal variation in circulating iron levels. A 12-hour overnight fast is required; avoid oral iron supplements for at least 24 to 48 hours prior to testing. Ferritin is an acute-phase reactant; measure concurrent hs-CRP to rule out falsely elevated ferritin from systemic inflammation or acute infection.
Reflexive Testing Protocol:
- Complete Iron Panel (Serum Iron, Total Iron-Binding Capacity, Ferritin, Transferrin Saturation Percentage)
- Soluble Transferrin Receptor (sTfR) and sTfR-Ferritin Index to differentiate iron deficiency anemia from anemia of chronic disease
- HFE Gene Mutation Analysis (C282Y, H63D) to screen for hereditary hemochromatosis in cases of persistent transferrin supersaturation
- High-sensitivity C-Reactive Protein (hs-CRP) and Erythrocyte Sedimentation Rate (ESR) to evaluate inflammatory status
- Upper and lower endoscopy (EGD and Colonoscopy) to rule out occult gastrointestinal blood loss in unexplained iron deficiency
Clinical Citations & Primary Literature (1)
- [1]Clinical Diagnostic Approach to Disorders of Iron Homeostasis - Blood (2021). PMID: 33621430
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Total Iron-Binding Capacity (TIBC) into overall healthspan optimization.